Pharmaceutical properties of paclitaxel and their effects on preparation and administration

Pharmacotherapy

Volumn 17, Issue 5 II SUPPL., 1997, Pages

  Trissel, Lawrence A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CHLORPROMAZINE; HYDROXYZINE; METHYLPREDNISOLONE; MITOXANTRONE; PACLITAXEL; SUCCINIC ACID;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; OVARY CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; PACLITAXEL; PLASTICIZERS; SOLUTIONS; VEHICLES;

EID: 0030861971     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Flora KP, Cradock JC, Quinn FR, et al. NCI investigational drugs - chemical information 1988. Bethesda, MD: National Cancer Institute, NIH, 1988:94-6.
2. Mead Johnson Oncology Products. Taxol (paclitaxel) injection prescribing information. Princeton, NJ; 1996.
3. Rieger MM. Surfactants. In: Liebermann HA, Rieger MM, Bunker GS, eds. Disperse systems, vol 1. New York: Marcel Dekker, 1988:285-366.
4. Trissel LA, Bready BB. Turbidimetric assessment of the compatibility of paclitaxel with selected other drugs during simulated Y-site injection. Am J Hosp Pharm 1992;49:1716-19.
5. United States Pharmacopeial Convention. U.S. Pharmacopeia, 23rd ed. Rockville, MD; 1995:1813-19.
6. Chin A, Ramakrishnan RR, Yoshimura NN, Jeong EWS, Nii LJ, DiMeglio LS. Paclitaxel stability and compatibility in polyolefin containers. Ann Pharmacother 1994;28:35-6.
7. Xu Q, Trissel LA, Martinez JF. Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32°C. Am J Hosp Pharm 1994;51:3058-60.
8. Waugh WN, Trissel LA, Stella VJ. Stability, compatibility, and plasticizer extraction of paclitaxel (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am J Hosp Pharm 1991;48:1520-4.
9. Pfeifer RW, Hale KN. Precipitation of paclitaxel during infusion by pump. Am J Hosp Pharm 1993;50:2518, 2521.
10. Cronquist SE, Daniels M. Precipitation of paclitaxel during infusion by pump. Am J Hosp Pharm 1993;50:2521.
11. Trissel LA, Xu Q, Kwan J, Martinez JF. Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets. Am J Hosp Pharm 1994;51:2804-10.
12. Pearson SD, Trissel LA. Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components. Am J Hosp Pharm 1993;50:1405-9.
13. Calley D, Autian J, Guess WL. Toxicology of a series of phthalate esters. J Pharm Sci 1966;55:158-62.
14. Harris GW. Conference on phthalate. Washington, DC: U.S. Department of Health and Human Services, 1981:189-92.
15. Kevy SV, Jacobson MS. Hepatic effects of phthalate ester plasticizer leached from polyvinyl chloride blood bags following transfusion. Environ Health Perspect 1982;45:57-64.
16. Gray TJ, Beamand JA, Lake BG, et al. Peroxisome proliferation in cultured rat hepatocytes produced by clofibrate and phthalate ester metabolites. Toxicol Lett 1982;10:273-9.
17. Warren JR, Lalwani ND, Ready JK. Phthalate esters as peroxisome proliferator carcinogens. Environ Health Perspect 1982;45:35-40.
18. Peters JW, Cook RM. Effect of phthalate esters on reproduction in rats. Environ Health Perspect 1973;3:91-4.
19. Rock G, Labow RS, Franklin C, Burnett R, Tocchi M. Hypotension and cardiac arrest in rats following infusion of mono(2-ethylhexyl)-phthalate (MEHP), a contaminant of stored blood. N Engl J Med 1987;316:1218.
20. Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of paclitaxel with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm 1993;50:300-4.
21. Xu Q, Zhang YP, Trissel LA, Gilbert GL, Martinez JF. Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions. Ann Pharmacother In press.